As shown in Table 1, there were no significant differences between patients from the three therapeutic subgroups in terms of age, sex, body mass index (BMI), stroke classifications (TOAST and OSCP), left ventricular ejection fraction (LVEF), liver function, including aspartate aminotransferase (AST) and alanine aminotransferase (ALT), low density lipoprotein (LDL), serum creatinine (sCr), WBCs, monocytes, red blood cells (RBCs) and platelets (PLTs). Here, GPT is linked to stroke disorder.